Roche Diagnostics Expands Its Footprint Into Kuwait

Roche Diagnostics, a world leader in biotechnology, announced today the official establishment of its new legal entity in Kuwait; an important milestone that grants the company the opportunity to expand its local footprint, as part of  its long-standing commitment to serving patients and communities across the country and the Middle East.

Supported by the Kuwait Direct Invest Promotion Authority (KDIPA), the company’s new license will allow for the expansion of local diagnostics operations and increased access for healthcare providers to the latest diagnostic tests; at a time where the demand for testing has increased, especially during COVID-19.

Moreover, this move further aligns with Roche’s commitment to serve the government and people of Kuwait by upscaling and expanding diagnostic testing and reinforcing the highest global standards and knowledge in the field where needed.

“We are very pleased to announce the official commencement of our legal presence in Kuwait today” said Dr. Vassilis Bakoyiannis, General Manager at Roche Diagnostics Kuwait. “We are also grateful for all the efforts deployed by the Kuwait Direct Investment Promotion Authority in enhancing Kuwait’s position as an innovation-based investment hub in the region, and value the country’s unwavering commitment towards further elevating the standards of healthcare,” he added.

The establishment of Roche’s new legal presence in Kuwait underscores the company’s dedication to supporting the Kuwaiti government in providing healthcare solutions relating to the prevention, diagnosis of various disease areas, including cardiovascular health, women’s health, infectious diseases, and others. Furthermore, Roche’s presence in Kuwait will expedite the company’s efforts in bringing the latest innovations and diagnostic technologies to support in upscaling patient care in the country’s healthcare institutions.

“By bringing in the latest diagnostic innovations to the country, we are able to better support healthcare professionals to make accurate and reliable clinical decisions. We are pleased to strengthen our presence in Kuwait and be closer to our patients and partners. Our mission remains to have our innovations accessible for every patient who needs them,” said Dr. Bakoyiannis.

 

SOURCE: TIMESKUWAIT 

Comments Post Comment

Leave a Comment

Submit